miR-205-5p Mediated Downregulation of PTEN Contributes to Cisplatin Resistance in C13K Human Ovarian Cancer Cells

被引：39
|
作者：
Shi, Xiaoyan [1 ,3 ]
Xiao, Lan [4 ]
Mao, Xiaolu [5 ]
He, Jinrong [1 ,3 ]
Ding, Yu [1 ,3 ]
Huang, Jin [1 ,3 ]
Peng, Caixia [1 ,3 ]
Xu, Zihui [1 ,2 ]
机构：
[1] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Key Lab Mol Diag Hubei Prov, Wuhan, Hubei, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Dept Endocnnol & Metab, Wuhan, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Cent Lab, Wuhan, Hubei, Peoples R China
[4] An Hui Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Hefei, Anhui, Peoples R China
[5] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongii Med Coll, Dept Clin Lab, Wuhan, Hubei, Peoples R China
来源：
FRONTIERS IN GENETICS | 2018年 / 9卷
基金：
中国国家自然科学基金;
关键词：
miR-205-5p; PTEN; cisplatin resistance; ovarian cancer; AKT; PANCREATIC-CANCER; INDUCED APOPTOSIS; TARGETING PTEN; LUNG-CANCER; INHIBITION; EXPRESSION; CARCINOMA; PATHWAY; LEADS;
D O I：
10.3389/fgene.2018.00555
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Cisplatin resistance is a major cause of treatment failure in advanced ovarian cancer. The limited evidence shows the paradoxical regulation of miR-205 on chemotherapy resistance in cancer. Herein, we found that miR-205-5p was enormously increased in cisplatin-resistant C13K ovarian cancer cells compared with its cisplatin-sensitive OV2008 parental cells using miRNA microarrays, which was further verified by quantitative PCR. Furthermore, we confirmed that inhibition of miR-205-5p upregulated PTEN and subsequently attenuated its downstream target p-AKT, which inversed C13K cells from cisplatin resistance to sensitivity. Our data suggest that miR-205-5p contributes to cisplatin resistance in C13K ovarian cancer cells may via targeting PTEN/AKT pathway.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells
    Yu, Pei-Ning
    Yan, Ming-De
    Lai, Hung-Cheng
    Huang, Rui-Lan
    Chou, Yu-Ching
    Lin, Wen-Chi
    Yeh, Li-Tzu
    Lin, Ya-Wen
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (03) : 542 - 551
  • [2] miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation
    Ma, Changpo
    Shi, Xuejun
    Guo, Wenchao
    Feng, Fukai
    Wang, Guangshun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (05) : 3525 - 3533
  • [3] MiR-205-5p promotes invasion and metastasis in breast cancer stem cells
    De Cola, A.
    Lamolinara, A.
    Lanuti, P.
    Rossi, C.
    Iezzi, M.
    Todaro, M.
    De Laurenzi, V
    CELL DEATH DISCOVERY, 2019, 5
  • [4] Long non-coding RNA derived miR-205-5p modulates human endometrial cancer by targeting PTEN
    Xin, Weijuan
    Liu, Xiaoxia
    Ding, Jingxin
    Zhao, Jing
    Zhou, Yang
    Wu, Qianyu
    Hua, Keqin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (11): : 2433 - 2441
  • [5] Gambogic Acid Improves Cisplatin Resistance of Bladder Cancer Cells through the Epithelial-Mesenchymal Transition Pathway Mediated by the miR-205-5p/ZEB1 Axis
    Mei, Yuxian
    Xu, Jun
    Li, Wenhua
    Chen, Shasha
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2024, 54 (03): : 354 - 362
  • [6] Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells
    Bao, Lingjie
    Jaramillo, Melba C.
    Zhang, Zhenbo
    Zheng, Yunxi
    Yao, Ming
    Zhang, Donna D.
    Yi, Xiaofang
    MOLECULAR MEDICINE REPORTS, 2015, 11 (01) : 91 - 98
  • [7] miR-205-5p Downregulation and ZEB1 Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast Cancer
    Kalinkova, Lenka
    Nikolaieva, Nataliia
    Smolkova, Bozena
    Ciernikova, Sona
    Kajo, Karol
    Bella, Vladimir
    Kajabova, Viera Horvathova
    Kosnacova, Helena
    Minarik, Gabriel
    Fridrichova, Ivana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
  • [8] miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance
    A De Cola
    S Volpe
    M C Budani
    M Ferracin
    R Lattanzio
    A Turdo
    D D'Agostino
    E Capone
    G Stassi
    M Todaro
    C Di Ilio
    G Sala
    M Piantelli
    M Negrini
    A Veronese
    V De Laurenzi
    Cell Death & Disease, 2015, 6 : e1823 - e1823
  • [9] miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance
    De Cola, A.
    Volpe, S.
    Budani, M. C.
    Ferracin, M.
    Lattanzio, R.
    Turdo, A.
    D'Agostino, D.
    Capone, E.
    Stassi, G.
    Todaro, M.
    Di Ilio, C.
    Sala, G.
    Piantelli, M.
    Negrini, M.
    Veronese, A.
    De laurenzi, V.
    CELL DEATH & DISEASE, 2015, 6 : e1823 - e1823
  • [10] Icariin inhibits the malignant progression of lung cancer by affecting the PI3K/Akt pathway through the miR-205-5p/PTEN axis
    Zhu, Fengjie
    Ren, Zhe
    ONCOLOGY REPORTS, 2022, 47 (06)
12345